A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment
Saved in:
Main Authors: | Hannah Meijs, Bochao Lin, Guido van Wingen, Evian Gordon, Damiaan Denys, Bieke De Wilde, Jan Van Hecke, Peter Niemegeers, Kristel van Eijk, Jurjen Luykx |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/0838a0e7f5b145c1b04cdd4e32dd312b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the role of Polygenetic risk scores for MDD treatment outcome in sex and different antidepressants groups
by: Bochao Lin, et al.
Published: (2021) -
Brainmarker-I: a transdiagnostic EEG biomarker predicting remission to various depression and ADHD treatments
by: Helena Voetterl, et al.
Published: (2021) -
Investigating EEG biomarker specificity to combined rTMS with psychotherapy: Psychotherapy, rTMS or sham? A blinded prediction study
by: Amourie Prentice, et al.
Published: (2021) -
Heartbeat evoked potential in major depressive disorder: Differential treatment prediction for antidepressant medication and rTMS
by: Lauren Zwienenberg, et al.
Published: (2021) -
Genetic risk for schizophrenia is associated with altered visually-induced gamma band activity: evidence from a population sample stratified polygenic risk
by: S. I. Dimitriadis, et al.
Published: (2021)